Deflazacort
- Strength
- 30 mg/1
- Form
- Tablet
- Class
- Corticosteroid
Upsher-Smith Laboratories, LLC
deflazacort
Listed by PTC Therapeutics, Inc.
| Dosage form | Suspension |
|---|---|
| Route | Oral |
| Drug class | Corticosteroid |
| Approval route | NDA — original brand approval |
| NDC code | 52856-505 |
| FDA application | NDA208685 |
| RxNorm concept | 153098 |
| Package sizes listed | 1 |
| Marketed since | September 2018 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Upsher-Smith Laboratories, LLC
Upsher-Smith Laboratories, LLC
Upsher-Smith Laboratories, LLC
Amneal Pharmaceuticals NY LLC
Amneal Pharmaceuticals NY LLC
Zydus Pharmaceuticals (USA) Inc.
AvKARE
Amneal Pharmaceuticals NY LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.